|
Solvent |
mg/mL |
mM |
| Solubility |
| Soluble in DMSO |
0.0 |
100.00 |
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.
Preparing Stock Solutions
The following data is based on the
product
molecular weight
266.34
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Chen G, Wang C, Zou L, Zhu J, Li Y, Qi C. Six-Step Total Synthesis of (±)-Conolidine. J Nat Prod. 2019 Nov 22;82(11):2972-2978. doi: 10.1021/acs.jnatprod.9b00302. Epub 2019 Nov 5. PMID: 31686504.
2: Mendis GDC, Berecki G, Morrisroe E, Pachernegg S, Li M, Varney M, Osborne PB, Reid CA, Halgamuge S, Petrou S. Discovering the pharmacodynamics of conolidine and cannabidiol using a cultured neuronal network based workflow. Sci Rep. 2019 Jan 15;9(1):121. doi: 10.1038/s41598-018-37138-w. PMID: 30644434; PMCID: PMC6333801.
3: Arita T, Asano M, Kubota K, Domon Y, Machinaga N, Shimada K. Discovery of conolidine derivative DS39201083 as a potent novel analgesic without mu opioid agonist activity. Bioorg Med Chem Lett. 2019 Aug 1;29(15):1938-1942. doi: 10.1016/j.bmcl.2019.05.045. Epub 2019 May 21. PMID: 31147104.
4: Naoe S, Yoshida Y, Oishi S, Fujii N, Ohno H. Total Synthesis of (+)-Conolidine by the Gold(I)-Catalyzed Cascade Cyclization of a Conjugated Enyne. J Org Chem. 2016 Jul 1;81(13):5690-8. doi: 10.1021/acs.joc.6b00720. Epub 2016 Jun 20. PMID: 27276227.
5: Tarselli MA, Raehal KM, Brasher AK, Streicher JM, Groer CE, Cameron MD, Bohn LM, Micalizio GC. Synthesis of conolidine, a potent non-opioid analgesic for tonic and persistent pain. Nat Chem. 2011 Jun;3(6):449-53. doi: 10.1038/nchem.1050. PMID: 21602859.
6: Arita T, Asano M, Kubota K, Domon Y, Machinaga N, Shimada K. Discovery of a novel bicyclic compound, DS54360155, as an orally potent analgesic without mu- opioid receptor agonist activity. Bioorg Med Chem Lett. 2019 Dec 1;29(23):126748. doi: 10.1016/j.bmcl.2019.126748. Epub 2019 Oct 19. PMID: 31676224.
7: Kam TS, Pang HS, Choo YM, Komiyama K. Biologically active ibogan and vallesamine derivatives from Tabernaemontana divaricata. Chem Biodivers. 2004 Apr;1(4):646-56. doi: 10.1002/cbdv.200490056. PMID: 17191876.
8: Huang Y, Yang Y, Song H, Liu Y, Wang Q. Synthesis of Structurally Diverse 2,3-Fused Indoles via Microwave-Assisted AgSbF6-Catalysed Intramolecular Difunctionalization of o-Alkynylanilines. Sci Rep. 2015 Aug 27;5:13516. doi: 10.1038/srep13516. PMID: 26310858; PMCID: PMC4550932.
9: Arita T, Asano M, Kubota K, Domon Y, Machinaga N, Shimada K. Discovery of DS34942424: An orally potent analgesic without mu opioid receptor agonist activity. Bioorg Med Chem. 2020 Nov 1;28(21):115714. doi: 10.1016/j.bmc.2020.115714. Epub 2020 Aug 18. PMID: 33065431.
10: Reisman SE. Medicinal chemistry: New lead for pain treatment. Nature. 2011 May 26;473(7348):458-9. doi: 10.1038/473458a. PMID: 21614069.
